quinazolines has been researched along with unc 0631 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Allali-Hassani, A; Arrowsmith, CH; Barsyte-Lovejoy, D; Brown, PJ; Chen, X; Frye, SV; He, Y; Herold, JM; Huang, J; Jin, J; Liu, F; Vedadi, M; Yates, CM | 1 |
Beizer, A; Belitsky, G; Bugaeva, P; Fedorov, D; Katz, R; Kirsanov, K; Lesovaya, E; Lizogub, O; Maksimova, V; Shalginskikh, N; Usalka, O; Vlasova, O; Yakubovskaya, M | 1 |
2 other study(ies) available for quinazolines and unc 0631
Article | Year |
---|---|
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.
Topics: Blotting, Western; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Enzyme Inhibitors; Female; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Male; Models, Molecular; Prostatic Neoplasms; Protein Binding; Protein Conformation; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2011 |
HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes.
Topics: Azacitidine; Azepines; DNA Methylation; Epigenesis, Genetic; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Phthalimides; Quinazolines; Tryptophan | 2021 |